To investigate the effect of 5-HT4R stimulation on tauopathy, we used two selective, high-affinity 5-HT4R partial agonists with good brain penetration (Johnson et al., 2012), prucalopride (3 mg/kg) and RS-67333 (2 mg/kg). Here, HTR4 is linked to tauopathy.